Segmed, a Palo Alto, CA-based provider of real-world imaging data for health innovation, raised $10.4M in Series A funding.
The round was led by iGan Partners and Advocate Health, with participation from Castellan Group, Engine Health Capital, Bold Brain Ventures, Fox Chase Cancer Center, and current investors including Y Combinator, Nina Capital, Nova Capital, Blumberg Capital, and Expeditions Fund.
The company intends to use the funds to further expand its medical imaging solutions for artificial intelligence development and real-world evidence.
Led by CEO Martin Willemink, Segmed collaborates with life-sciences, health care and technology firms to streamline access to medical imaging studies for advancing biopharmaceutical R&D, AI development and enhancing global health care initiatives. It acquires, de-identifies, standardizes and subsequently provides medical imaging data to researchers and innovators in AI/ML and real-world imaging data (RWiD) through its proprietary data platform.
By partnering with health care locations and imaging clinics across five continents, researchers and AI developers can access the studies they need.
The current Series A round followed a financing by Flashpoint Growth Debt Fund received in 2023.
FinSMEs
03/09/2024